[PR Newswire] Avantor, Inc. (NYSE: AVTR) announced that its performance for the third quarter of 2026 exceeded management's expectations for revenue and adjusted earnings per share.
Emmanuel Ligner, President and CEO of Avantor, said: “We are pleased to have returned to year-over-year growth in the third quarter. Our Revival journey is not over, but this performance reflects the dedication of our employees and the progress we’ve made in strengthening our strategic focus and enhancing execution. Third-quarter results exceeded our expectations in both revenue and adjusted earnings per share, while we generated strong free cash flow, enabling us to further strengthen our balance sheet.”
“VWR Distribution & Services delivered improved revenue performance for another quarter, with organic growth accelerating to 5.8%; Bioscience & Medtech Products also resumed organic growth as expected. We believe that improved execution and stronger end markets have laid the foundation for sustainable revenue growth, and we will continue to focus on execution to build on this positive momentum,” added Ligner.
For the three months ended September 30, 2026, net sales amounted to $1.6983 billion, representing a 4.6% increase compared to the third quarter of 2025. Foreign exchange translation had a negative impact of 0.6%, resulting in a 5.2% increase in net sales on an organic basis.
Net income turned from a net loss of $711.8 million in the third quarter of 2025 to a net income of $203.4 million, with a net profit margin of 12.0%; adjusted net income was $146.4 million, below $151.1 million in the same period last year. Adjusted EBITDA was $256.9 million, with an adjusted EBITDA profit margin of 15.1%.
Operating profit was $139.5 million, with an operating profit margin of 8.2%; adjusted operating profit was $227.6 million, with an adjusted operating profit margin of 13.4%.
Under GAAP, diluted earnings per share were $0.30; adjusted diluted earnings per share were $0.22.
Third Quarter 2026 Segment Performance
VWR Distribution & Services
- Net revenue was $1.2338 billion, a 5.0% increase from $1.175 billion in the third quarter of 2025. Foreign exchange translation negatively impacted revenue by 0.8%, resulting in an organic revenue growth of 5.8%.
- Adjusted operating profit was $119.4 million, lower than $132.0 million in the same period last year. The adjusted operating profit margin was 9.7%. The adjusted operating profit margin decreased compared to the prior year due to an unfavorable product mix and higher SG&A expenses, partially offset by higher sales volume.
Bioscience and MedTech Products
- Net revenue was $464.5 million, a 3.5% increase from $448.8 million in the third quarter of 2025. Foreign exchange translation had a negative impact of 0.1%, resulting in an organic revenue growth of 3.6%.
- Adjusted operating profit was $123.4 million, up from $119.3 million in the same period last year. The adjusted operating profit margin was 26.6%. The adjusted operating profit margin remained flat compared to the prior year, as higher sales volume and improved commercial execution were partially offset by increased SG&A expenses.
Avantor states that adjusted operating profit is a metric used by the company under GAAP to measure segment profitability and is also used by management to evaluate the performance of business segments.
Balance Sheet and Cash Flow
As of September 30, 2026, the company's total debt amounted to $3.6997 billion, and cash and cash equivalents totaled $464.3 million.
As of September 30, 2026, the GAAP net leverage ratio was 9.6x, and the adjusted net leverage ratio was 3.1x.
For the three months ended September 30, 2026, operating cash flow was $195.1 million, and free cash flow was $156.2 million.
Updated 2026 Guidance
Avantor updated its fiscal year 2026 financial guidance.
The fiscal year 2026 assumptions include:
- The reported revenue growth range is 1.5% to 2.0%, including a 0.75% favorable impact from foreign exchange.
- The euro/dollar composite exchange rate is 1.15.
- Net interest expense is expected to decrease slightly compared to fiscal year 2025.
- The adjusted effective tax rate ranges from 22.0% to 22.5%.
- The fully diluted number of shares is 679 million.
Telephone conference
The company will hold a conference call on October 28, 2026, at 8:00 AM Eastern Time to discuss its earnings. A live webcast and presentation materials, as well as a replay, will be available on the Avantor Investor Relations website.
About Avantor
Avantor is a leading life sciences tools company and a global supplier of critical products and services to the life sciences and advanced technology industries. The company partners with customers at every step of scientific discovery to drive breakthroughs in medicine, healthcare, and technology. Its portfolio supports key research and manufacturing activities across more than 300,000 customer sites in over 180 countries. For more information, visit corporate.avantorsciences.com and follow the company on LinkedIn, X (Twitter), and Facebook.
Use of Non-GAAP Financial Measures
To evaluate performance, the company monitors several key metrics. Where appropriate, the company supplements its GAAP-derived operating results with certain non-GAAP financial measures. The company believes these metrics assist investors, creditors, and other stakeholders in assessing its performance. These measures should not be viewed in isolation or as a substitute for reported GAAP results, as they may include or exclude items different from those in comparable GAAP measures and may not be comparable to similarly titled measures used by other companies. Instead, these measures should be viewed as a complementary way to observe the company’s operating performance to gain a more comprehensive understanding of the business. The company strongly encourages investors to read its full consolidated financial statements filed with the U.S. Securities and Exchange Commission (SEC), rather than relying solely on any single financial metric or communication.
The non-GAAP financial measures used in this press release include: organic sales growth (decline), adjusted operating profit, adjusted operating profit margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted earnings per share, adjusted net leverage ratio, free cash flow, and free cash flow conversion rate.
Organic net sales growth (decline) excludes the impact of revenue from acquisitions and divestitures over the past year, as well as the effects of foreign exchange fluctuations, on net sales changes during the reporting period. The company believes this metric helps investors consistently measure and evaluate the underlying business performance of each segment and across the periods presented, and management uses this same metric for the same purpose.
Adjusted operating profit refers to operating profit or loss adjusted for the following items: (i) amortization of acquired intangible assets, (ii) expenses related to certain asset impairments, (iii) gains or losses from business disposals, and (iv) other specified adjustments. Adjusted operating profit margin is calculated as adjusted operating profit divided by GAAP net revenue. The company believes these metrics assist investors in analyzing the underlying trends of the business on a consistent basis, and management uses these metrics for the same purpose. Additionally, adjusted operating profit is the profitability metric used by the company for segment reporting under GAAP.
Adjusted EBITDA refers to net income or loss adjusted for the following items: (i) interest expense, (ii) income tax expense, (iii) amortization of acquired intangible assets, (iv) depreciation expense, (v) debt extinguishment losses, (vi) expenses related to certain asset impairments, (vii) gains or losses from business sales, and (viii) other certain adjustments. Adjusted EBITDA margin is calculated as adjusted EBITDA divided by GAAP net revenue. The company believes these metrics assist investors in analyzing the underlying trends of the business on a consistent basis, and management uses these metrics for the same purpose.
Adjusted net income refers to net income or loss, adjusted first for the following items: (i) amortization of acquired intangible assets, (ii) debt extinguishment losses, (iii) expenses related to certain asset impairments, (iv) gains or losses from business sales, and (v) other specified adjustments; followed by the addition or subtraction of the estimated incremental income tax impact based on the aforementioned pre-tax adjustments, resulting in adjusted net income. The company believes this metric assists investors in analyzing the underlying business performance on a consistent basis, and management uses this metric for the same purpose.
Adjusted earnings per share is calculated by dividing adjusted net income by the GAAP diluted weighted-average shares outstanding, adjusted for anti-dilutive instruments. The company believes this metric helps investors analyze the underlying trends of the business on a consistent basis, and management uses this metric for the same reason.
The adjusted net leverage ratio equals total debt minus cash and cash equivalents, divided by adjusted EBITDA for the past 12 months (excluding stock-based compensation expenses and incorporating the expected run-rate impact of cost synergies, as well as the incremental results from completed acquisitions and divestitures, assuming these transactions occurred on the first day of the 12-month period). The company believes this metric helps investors evaluate and measure the company’s capital allocation strategy and underlying business trends, and management uses this metric for the same purpose.
Free cash flow equals operating cash flow minus capital expenditures, plus direct transaction costs related to acquisitions and divestitures and income taxes paid (if applicable). The free cash flow conversion rate is calculated as free cash flow divided by adjusted net profit. The company believes these metrics help investors understand the company’s ability to generate cash for financing or investment activities, and management uses these metrics for the same reason.
A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures is included in the table accompanying this press release.
Forward-Looking and Cautionary Statements
This press release contains forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is protected by the safe harbor provisions established by the Private Securities Litigation Reform Act of 1995. All statements other than historical fact statements contained in this press release are forward-looking statements. Forward-looking statements involve the company’s current expectations and predictions regarding its financial condition, operating results, plans, objectives, future performance, and business. These statements may be preceded by, followed by, or include words such as “aim,” “anticipate,” “assumption,” “believe,” “continue,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “intend,” “likely,” “long-term,” “near-term,” “objective,” “opportunity,” “outlook,” “plan,” “potential,” “project,” “projection,” “prospects,” “seek,” “target,” “trend,” “can,” “could,” “may,” “should,” “would,” “will,” and their negative forms and other words of similar meaning.
Forward-looking statements are inherently subject to risks, uncertainties, and assumptions and do not constitute a guarantee of performance. Do not place undue reliance on these statements. The company makes these forward-looking statements based on current expectations and projections regarding future events. Although the company believes the assumptions underlying these forward-looking statements are reasonable, it cannot guarantee that these assumptions or expectations will prove correct. Factors that could cause these risks, uncertainties, and assumptions include, but are not limited to, those described in the "Risk Factors" section of the company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, and such risk factors may be updated from time to time in the company’s periodic filings with the SEC.
All forward-looking statements attributable to the company or persons acting on its behalf are subject to the overall qualifications set forth in the above cautionary statements. In addition, all forward-looking statements are made only as of the date of this press release. Except as required by federal securities laws, the company undertakes no obligation to publicly update or revise any forward-looking statements due to new information, future events, or other reasons.
Investor Relations Contact
Chris Fidyk
Vice President of Investor Relations
Avantor
[email protected]
Global Media Contact
Valerie Collado
Director of External Communications and Community Impact
Avantor
484-885-9338
[email protected]


